Finally, we validated the potential of ITGAV to identify hybrid/plastic cancer cells by analyzing the expression of ITGAV and EpCAM in epithelial, mixed, and mesenchymal mouse cSCCs through standard clinical methods such as IF (Fig. 2E). The gene discussed is ITGAV; the disease is cancer.